Your browser doesn't support javascript.
loading
High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata.
de Jong, Annemieke; Jabbari, Ali; Dai, Zhenpeng; Xing, Luzhou; Lee, Dustin; Li, Mei Mei; Duvic, Madeleine; Hordinsky, Maria; Norris, David A; Price, Vera; Mackay-Wiggan, Julian; Clynes, Raphael; Christiano, Angela M.
Afiliação
  • de Jong A; Department of Dermatology and.
  • Jabbari A; Department of Dermatology and.
  • Dai Z; Department of Dermatology and.
  • Xing L; Department of Pathology, Columbia University, New York, New York, USA.
  • Lee D; Department of Dermatology and.
  • Li MM; Department of Dermatology and.
  • Duvic M; Department of Dermatology, MD Anderson Cancer Center, Houston, Texas, USA.
  • Hordinsky M; Department of Dermatology, University of Minnesota, Minneapolis, Minnesota, USA.
  • Norris DA; Department of Dermatology, University of Colorado, Denver, Colorado, USA.
  • Price V; Department of Dermatology, UCSF, San Francisco, California, USA.
  • Mackay-Wiggan J; Department of Dermatology and.
  • Clynes R; Department of Dermatology and.
  • Christiano AM; Department of Dermatology and.
JCI Insight ; 3(19)2018 10 04.
Article em En | MEDLINE | ID: mdl-30282836
ABSTRACT
Alopecia areata (AA) is an autoimmune disease in which cytotoxic T cells specifically target growing hair follicles. We used high-throughput TCR sequencing in the C3H/HeJ mouse model of AA and in human AA patients to gain insight into pathogenic T cell populations and their dynamics, which revealed clonal CD8+ T cell expansions in lesional skin. In the C3H/HeJ model, we observed interindividual sharing of TCRß chain protein sequences, which strongly supports a model of antigenic drive in AA. The overlap between the lesional TCR repertoire and a population of CD8+NKG2D+ T cells in skin-draining lymph nodes identified this subset as pathogenic effectors. In AA patients, treatment with the oral JAK inhibitor tofacitinib resulted in a decrease in clonally expanded CD8+ T cells in the scalp but also revealed that many expanded lesional T cell clones do not completely disappear from either skin or blood during treatment with tofacitinib, which may explain in part the relapse of disease after stopping treatment.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Autoimunes / Receptores de Antígenos de Linfócitos T / Linfócitos T CD8-Positivos / Alopecia em Áreas Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adolescent / Adult / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: JCI Insight Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Autoimunes / Receptores de Antígenos de Linfócitos T / Linfócitos T CD8-Positivos / Alopecia em Áreas Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adolescent / Adult / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: JCI Insight Ano de publicação: 2018 Tipo de documento: Article